PPA
BNGO icon

Parametric Portfolio Associates’s Bionano Genomics BNGO Stock Holding History

Parametric Portfolio Associates’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$112K Buy
72
+1
+1% +$1.35K ﹤0.01% 3549
2021
Q4 		$127K Sell
71
-50
-41% -$134K ﹤0.01% 3516
2021
Q3 		$400K Buy
121
+38
+46% +$133K ﹤0.01% 3195
2021
Q2 		$367K Buy
+83
New +$328K ﹤0.01% 3200

Other funds holding BNGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $38.6B AUM 35.31% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Parametric Portfolio Associates's BNGO Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Bionano Genomics (BNGO) stake by 1.4% in Q1 2022, buying an estimated $1.35K and bringing the position to 72 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #3549.

Parametric Portfolio Associates first reported a position in BNGO in Q2 2021 and has held it in 4 quarters since. The position peaked at $400K in Q3 2021. 148 funds tracked by Wall St. Rank hold BNGO as of Q1 2022.

  • Parametric Portfolio Associates held 72 shares of Bionano Genomics worth $112K as of Q1 2022.
  • Parametric Portfolio Associates bought 1 Bionano Genomics share in Q1 2022, an estimated $1.35K.
  • Bionano Genomics made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3549 holding.
  • Parametric Portfolio Associates first reported a position in Bionano Genomics in Q2 2021 and has held it in 4 quarters since.
  • Parametric Portfolio Associates's Bionano Genomics position peaked at $400K in Q3 2021.
  • 148 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.